Faculty

Institution

Unit

Venue

Guangdi Wang

Professor of Chemistry

Xavier University of Louisiana

Affiliations

Department Of Chemistry

Department Of Mass Communication

Department Of Pharmacy Practice

Xavier University of Louisiana

Guangdi Wang is currently serving as a Chemistry Professor of Chemistry at Xavier University of Louisiana.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Guangdi Wang

Xavier University of Louisiana

Professor of Chemistry

You can click a keyword to filter the displayed items

pharmacology medicinal chemistry therapeutic targets biochemistry drug discovery medicinal research oncology tumor biology cancer research cell biology pharmaceutical chemistry prostate cancer anti-cancer agents cancer biology breast cancer cancer treatment cancer cells medicine molecular cancer drug development natural product research enzyme inhibition oncogenes pharmacotherapy tumor targeting future medicinal chemistry pharmacological research stem cell research cancer genomics cancer discovery synthetic chemistry pharmaceutics pharmaceutical sciences prostate cancer cells cellular therapy brain tumor research natural product synthesis peptide science drug targeting signaling pathways breast oncology respiratory medicine ion structure endocrine-related cancers novel therapies pharmaceutical research heterocycle chemistry tumor suppressors biological evaluation anti-prostate cancer agents polycyclic aromatic hydrocarbons soil contamination cluster chemistry cancer genetics translational proteomics therapeutic efficacy mesenchymal stem cells chemoprevention strategies proteomic analysis pharmacokinetic studies antiproliferative evaluation persistent organic pollutants soil chemistry oncogenic agent ion process bioassay-guided isolation histone deacetylase inhibitors curcumin-based anticancer agents structure-activity relationship letrozole resistance novel inhibitors thiazole derivatives potential treatment boronic prodrug enhanced bioavailability osteogenic activity gynecology cancer letter drug metabolism metabolomics biostatistics psychoneuroendocrinology analytical toxicology molecular pharmacology carcinogenesis biomarkers metabolic pathways metabolism oxidative stress systems biology proteomics cell metabolism clinical proteomics biochemical sciences chemical biology in vitro toxicology bioactive compounds ovarian cancer pharmacognosy environmental toxicology physiology ecotoxicology toxicology gynecologic oncology proteome research molecular metabolism endocrinology reproductive endocrinology regulatory toxicology molecular biology pathology

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 4605: Brigatinib Based Degraders as a Therapeutic Strategy for Triple Negative Breast Cancer. Cancer Research (2026)

radiation oncologytherapeutic strategyabstract 4605therapeutic targetsbreast oncologyanti-cancer agentsoncologybreast canceroncogenescancer cellscancer treatmentcell biology

Abstract Lb068: Oral Fulvestrant Nanoparticles Deliver High, Sustained Exposure: An Alternative to Im Injection. Cancer Research (2026)

im injectionnanomedicinetoxicologynanoparticlestranslational medicinein vitro toxicologynano-drug deliveryoral fulvestrant nanoparticlesdrug delivery systemstherapeutic nanomaterialsdrug deliverycontrolled releasepharmaceutical nanotechnologyabstract lb068nanotoxicologypharmacologybiomedical engineeringnanoparticle researchnanomaterials

Developing Orally Active Estrogen Receptor Degraders by Conjugation of Boronic Tamoxifen and Cereblon Ligands. European Journal of Medicinal Chemistry (2026)

receptorspharmacologyreproductive endocrinologyfuture medicinal chemistryendocrinologygynecologic oncologymolecular cancertherapeutic targetsmolecular pharmacologybreast cancermedicinal researchpsychoneuroendocrinologycancer lettergynecologyovarian cancerpharmacological researchcell biology

Discovery of Hiv-1 Integrase Protac Degraders With Potent Activity Against Viral Infection. SSRN Electronic Journal (2026)

hivantiviral researchpharmacologyfuture medicinal chemistryantiviral drugsbiomolecular engineeringvirologydrug discoveryhuman retrovirusviral infectionpotent activityantiviral drug developmentbiochemistry

Braf V600E ‐Protac Versus Inhibitors in Melanoma Cells: Deep Transcriptomic Characterization. Clinical and Translational Medicine (2025)

carcinogenesismelanomacancer researchmolecular cancermelanoma cellscancer genomicsmolecular cell biologyoncogenescancer cellscancer biologytumor biologycell biology

Rna Sequencing Identifies Novel Signaling Pathways and Potential Drug Target Genes Induced by Fosl1 in Glioma Progression and Stemness. Biologics (2025)

signaling pathwaysgliomasbrain tumor researchtherapeutic targetsmolecular cell biologymolecular biologyglioma progressiononcogenescancer cellscancer biologytumor biologycell biology

The Pivotal Role of Nf-κB in Glioblastoma: Mechanisms of Activation and Therapeutic Implications. International Journal of Molecular Sciences (2025)

immunologycell deathpharmacologygliomaspivotal rolebrain tumor researchmolecular cancertherapeutic targetstherapeutic implicationsanti-cancer agentsneuro-oncologycancer cellscancer biologytumor biologycell biology

Trim21 Functions as an Oncogene in Glioblastoma by Transactivating Fosl1 and Promoting the Ubiquitination of P27. Cell Communication and Signaling (2025)

trim21 functionsgliomascell regulationbrain tumor researchtumor suppressorstherapeutic targetsmolecular cell biologymolecular biologyoncogenic agentoncogenescancer cellscancer biologypathologytumor biologycell biology

Discovery of Oral Degraders of the Ros1 Fusion Protein With Potent Activity Against Secondary Resistance Mutations. Journal of Medicinal Chemistry (2024)

molecular researchoral degradersprotein functionmolecular cell biologymolecular biologydna repairros1 fusion proteinprotein sciencemutagenesis (molecular biology technique)secondary resistance mutationsbiochemistry

Licochalcone A-Inspired Chalcones: Synthesis and Their Antiproliferative Potential in Prostate Cancer Cells. Molecules (2024)

Roxana Gonzalez DoradoEsveidy Isabel Oceguera NavaGuanglin ChenQiang ZhangGuangdi WangQiao-Hong Chen

licochalcone a-inspired chalconesmolecular scienceanti-cancer agentsmolecular biologychemistryantiproliferative potentialprostate cancer cellsprostate cancerbiochemistry

1
2
3
4
5
17
10 / page

Guangdi Wang

Professor of Chemistry

Xavier University of Louisiana

Affiliations

Department Of Chemistry

Department Of Mass Communication

Department Of Pharmacy Practice

Xavier University of Louisiana

Guangdi Wang is currently serving as a Chemistry Professor of Chemistry at Xavier University of Louisiana.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Guangdi Wang

Xavier University of Louisiana

Professor of Chemistry

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 4605: Brigatinib Based Degraders as a Therapeutic Strategy for Triple Negative Breast Cancer. Cancer Research (2026)

radiation oncologytherapeutic strategyabstract 4605therapeutic targetsbreast oncologyanti-cancer agentsoncologybreast canceroncogenescancer cellscancer treatmentcell biology

Abstract Lb068: Oral Fulvestrant Nanoparticles Deliver High, Sustained Exposure: An Alternative to Im Injection. Cancer Research (2026)

Developing Orally Active Estrogen Receptor Degraders by Conjugation of Boronic Tamoxifen and Cereblon Ligands. European Journal of Medicinal Chemistry (2026)

Discovery of Hiv-1 Integrase Protac Degraders With Potent Activity Against Viral Infection. SSRN Electronic Journal (2026)

Braf V600E ‐Protac Versus Inhibitors in Melanoma Cells: Deep Transcriptomic Characterization. Clinical and Translational Medicine (2025)

carcinogenesismelanomacancer researchmolecular cancermelanoma cellscancer genomicsmolecular cell biologyoncogenescancer cellscancer biologytumor biologycell biology

Rna Sequencing Identifies Novel Signaling Pathways and Potential Drug Target Genes Induced by Fosl1 in Glioma Progression and Stemness. Biologics (2025)

signaling pathwaysgliomasbrain tumor researchtherapeutic targetsmolecular cell biologymolecular biologyglioma progressiononcogenescancer cellscancer biologytumor biologycell biology

The Pivotal Role of Nf-κB in Glioblastoma: Mechanisms of Activation and Therapeutic Implications. International Journal of Molecular Sciences (2025)

Trim21 Functions as an Oncogene in Glioblastoma by Transactivating Fosl1 and Promoting the Ubiquitination of P27. Cell Communication and Signaling (2025)

Discovery of Oral Degraders of the Ros1 Fusion Protein With Potent Activity Against Secondary Resistance Mutations. Journal of Medicinal Chemistry (2024)

Licochalcone A-Inspired Chalcones: Synthesis and Their Antiproliferative Potential in Prostate Cancer Cells. Molecules (2024)

Roxana Gonzalez DoradoEsveidy Isabel Oceguera NavaGuanglin ChenQiang ZhangGuangdi WangQiao-Hong Chen

licochalcone a-inspired chalconesmolecular scienceanti-cancer agentsmolecular biologychemistryantiproliferative potentialprostate cancer cellsprostate cancerbiochemistry

1
2
3
4
5
17
10 / page